Schirwani-Hartl, N.; Palmrich, P.; Haberl, C.; Perkmann-Nagele, N.; Kiss, H.; Berger, A.; Rittenschober-Böhm, J.; Kasprian, G.; Kienast, P.; Khalil, A.;
et al. Biweekly Versus Monthly Hyperimmune Globulin Therapy for Primary Cytomegalovirus Infection in Pregnancy. J. Clin. Med. 2023, 12, 6776.
https://doi.org/10.3390/jcm12216776
AMA Style
Schirwani-Hartl N, Palmrich P, Haberl C, Perkmann-Nagele N, Kiss H, Berger A, Rittenschober-Böhm J, Kasprian G, Kienast P, Khalil A,
et al. Biweekly Versus Monthly Hyperimmune Globulin Therapy for Primary Cytomegalovirus Infection in Pregnancy. Journal of Clinical Medicine. 2023; 12(21):6776.
https://doi.org/10.3390/jcm12216776
Chicago/Turabian Style
Schirwani-Hartl, Nawa, Pilar Palmrich, Christina Haberl, Nicole Perkmann-Nagele, Herbert Kiss, Angelika Berger, Judith Rittenschober-Böhm, Gregor Kasprian, Patric Kienast, Asma Khalil,
and et al. 2023. "Biweekly Versus Monthly Hyperimmune Globulin Therapy for Primary Cytomegalovirus Infection in Pregnancy" Journal of Clinical Medicine 12, no. 21: 6776.
https://doi.org/10.3390/jcm12216776
APA Style
Schirwani-Hartl, N., Palmrich, P., Haberl, C., Perkmann-Nagele, N., Kiss, H., Berger, A., Rittenschober-Böhm, J., Kasprian, G., Kienast, P., Khalil, A., & Binder, J.
(2023). Biweekly Versus Monthly Hyperimmune Globulin Therapy for Primary Cytomegalovirus Infection in Pregnancy. Journal of Clinical Medicine, 12(21), 6776.
https://doi.org/10.3390/jcm12216776
